Skip to main content
Premium Trial:

Request an Annual Quote

Agilent SureSelect Human All Exon V6, V6+UTR, and V6+COSMIC

Agilent Technologies has added the SureSelect Human All Exon V6, V6+UTR, and V6+COSMIC to its line of target-enrichment products. The new products are designed to address the limitations of exome sequencing, targeting hard-to-capture and multi-mapping regions. The products also increase the sensitivity of variant calling and minimize false negative calls, Agilent said. 

The new products are compatible with the custom design capabilities of SureDesign, the sample quality control provided by the Agilent 2100 Bioanalyzer and 2200 Tapestation, the reproducible performance of the Bravo Automated Liquid Handling Platform, and the guided analysis workflows enabled by SureCall software.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.